BB Biotech Risk Adjusted Performance
| BION Stock | | | CHF 44.65 -0.45 -1.00% |
The Risk Adjusted Performance lookup presents technical context for BB Biotech AG and related instruments. Coverage depends on data availability and normalization;
Equity Screeners provides additional screening context. BB Biotech has a market cap of 2.46 B, operating margin of 98.0%, ROE of 22.83%.
Trending Equities can help frame allocation decisions. The allocation includes a position in BB Biotech AG within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in metropolitan statistical area.
BB Biotech AG has current Risk Adjusted Performance of
-0.0034.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | -0.0034 | |
BB Biotech Risk Adjusted Performance Peers Comparison
BION Risk Adjusted Performance Relative To Other Indicators
BB Biotech AG is rated
below average for risk adjusted performance across the peer group. It is currently under evaluation for maximum drawdown across the peer group .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.